Full Year 2020 Hutchison China MediTech Ltd Earnings Call Transcript
Okay. Thank you. This is Christian Hogg, CEO of HUTCHMED. And today, we welcome everybody to this 2020 -- fiscal year 2020 results and business update presentation.
On the line, I also have Dr. Wei-Guo Su, our Chief Scientific Officer and Head of Research and Development. I have Johnny Cheng, our Chief Financial Officer, and I have Dr. Marek Kania, our Chief Medical Officer in the U.S. and Head of our International Operations.
What I'm planning to do today is, given this is an hour-long session, is spend about 30 minutes, 25 to 30 minutes on the presentation. I'll go through it relatively quickly as it's all fairly well laid-out in our announcement that's just been out for an hour or so. And then I'll leave the second half of the hour for Q&A. And that's an opportunity for the broader team that we have here to answer any questions that you might have.
So if we go to Page #3 of the presentation, I'll just touch very quickly on the new name, the new corporate identity, HUTCHMED. As many of you on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |